[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]

MLA

Elena Galli, et al. “[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy].” Farmeconomia: Health Economics and Therapeutic Pathways, vol. 23, no. 1, June 2022. EBSCOhost, https://doi.org/10.7175/fe.v23i1.1527.

APA

Elena Galli, Maria Paola Pedone, Miryana Dobreva, Rossella Bitonti, & Roberta Di Turi. (2022). [Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]. Farmeconomia: Health Economics and Therapeutic Pathways, 23(1). https://doi.org/10.7175/fe.v23i1.1527

Chicago

Elena Galli, Maria Paola Pedone, Miryana Dobreva, Rossella Bitonti, and Roberta Di Turi. 2022. “[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy].” Farmeconomia: Health Economics and Therapeutic Pathways 23 (1). doi:10.7175/fe.v23i1.1527.